TechNavio's analysts forecast the OTC Pharmaceuticals Market in the APAC region to grow at a CAGR of 3.4 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increasing switch from prescription to OTC drugs. The OTC Pharmaceuticals market in the APAC region has also been witnessing the trend of an increasing number of mergers and acquisitions. However, the product recalls by the US FDA could pose a challenge to the growth of this market.... Research Beam Model: Research Beam Product ID: 16361 2000 USD New
Over-the-counter Pharmaceuticals Market in the Asia Pacific Region 2012-2016
 

Over-the-counter Pharmaceuticals Market in the Asia Pacific Region 2012-2016

Over-the-counter Pharmaceuticals Market in the Asia Pacific Region 2012-2016

Category : Healthcare

request-discount
TOLL FREE
+1-971-202-1575
------------ Or -------------
help@researchbeam.com

TechNavio's analysts forecast the OTC Pharmaceuticals Market in the APAC region to grow at a CAGR of 3.4 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increasing switch from prescription to OTC drugs. The OTC Pharmaceuticals market in the APAC region has also been witnessing the trend of an increasing number of mergers and acquisitions. However, the product recalls by the US FDA could pose a challenge to the growth of this market. 

TechNavio's report, the OTC Pharmaceuticals Market in the APAC Region 2012-2016, has been prepared based on an in-depth market analysis with inputs from industry experts. The report focuses on the APAC region; it also covers the OTC Pharmaceuticals market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.

The key vendors dominating this market space are Johnson & Johnson, GlaxoSmithKline plc, Novartis International AG, and Bayer Healthcare AG.
 
The other vendors mentioned in the report are Sanofi S.A., Reckitt Benckiser plc, Boehringer Ingelheim GmbH, Merck and Co. Inc., Pfizer Inc., Takeda Pharmaceutical Co. Ltd., Eisai Co. Ltd., Roche Holding Ltd., Procter and Gamble, Taisho Pharmaceutical, Bristol Myers Squibb Co., and Schering-Plough Corp., Mitsubishi Tanabe Pharma Corp., Sigma Pharmaceuticals plc, Hubei Biocause Heilen Pharmaceutical Co. Ltd., United Laboratories Inc., Daewoong Pharmaceutical Co. Ltd., Bukwang Pharmaceutical Co. Ltd., Vida Laboratories Ltd., and Cipla Ltd.

Key questions answered in this report:
What will the market size be in 2016 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by the key vendors?
What are the strengths and weaknesses of the key vendors?

01. Executive Summary

02. Introduction

03. Market Coverage


Business Overview

Product Offerings

04. Market Landscape

04.1 Market Size and Forecast

04.2 Market Segmentation

04.3 Five Forces Analysis

05. Key Leading Countries

Japan

China

India

06. Vendor Landscape

07. Buying Criteria

08. Market Growth Drivers

09. Drivers and their Impact

10. Market Challenges

11. Impact of Drivers and Challenges

12. Market Trends

13. Key Vendor Analysis


13.1 Johnson & Johnson

Business Overview

Key Information

SWOT Analysis

13.2 GlaxoSmithKline plc

Business Overview

Key Information

SWOT Analysis

13.3 Novartis International AG

Business Overview

Key Information

SWOT Analysis

13.4 Bayer HealthCare AG

Business Overview

Key Information

SWOT Analysis

14. Other Reports in this Series



List of Exhibits:

Exhibit 1: Over-the-counter Pharmaceuticals Market in the APAC Region 2012–2016 (US$ billion)

Exhibit 2: Over-the-counter Pharmaceuticals Market in the APAC Region Segmentation

Exhibit 3: Over-the-counter Pharmaceuticals Market in the APAC Region Segmentation 2012

Exhibit 4: Over-the-counter Pharmaceuticals Market in the APAC Region by Vendor Segmentation 2012

Exhibit 5: Business Segmentation of Johnson & Johnson

Exhibit 6: Business Segmentation of GlaxoSmithKline plc

Exhibit 7: Business Segmentation of Novartis International AG

Exhibit 8: Business Segmentation of Bayer HealthCare AG



Enquiry Before Buy